RIBOPRO announces groundbreaking research on antifibrotic effects of mRNA
Oss, the Netherlands, 9 October 2024 — RIBOPRO announces the publication of a new research article by López-Cerdá et al., titled “Antifibrotic and Pro-Regenerative Effects of SMAD3 siRNA and Collagen I mRNA Loaded Lipid.” This groundbreaking study utilized RIBOPRO’s off-the-shelf eGFP mRNA and custom mRNA to explore innovative methods for combating fibrosis and promoting tissue regeneration. The research focuses on the use of lipid nanoparticles loaded with SMAD3 siRNA and Collagen I mRNA, which may pave the way for new therapeutic strategies to treat fibrotic diseases and advance regenerative medicine.
This collaboration exemplifies RIBOPRO’s commitment to driving innovation and supporting research that pushes the boundaries of mRNA technology. These findings not only enhance our understanding of disease treatment but also provide valuable insights for future therapeutic development.
Find more news here.